No Data
No Data
Improved Revenues Required Before Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock's 30% Jump Looks Justified
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Revelation Biosciences (REVB)
Why Investors Shouldn't Be Surprised By Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) 27% Share Price Plunge